Haemonetics Corporation (HAE)
NYSE: HAE
· Real-Time Price · USD
67.69
-0.15 (-0.22%)
At close: May 30, 2025, 3:59 PM
67.71
0.03%
After-hours: May 30, 2025, 05:16 PM EDT
-0.22% (1D)
| Bid | 66 |
| Market Cap | 3.25B |
| Revenue (ttm) | 1.36B |
| Net Income (ttm) | 167.68M |
| EPS (ttm) | 3.32 |
| PE Ratio (ttm) | 20.39 |
| Forward PE | 13.95 |
| Analyst | Buy |
| Ask | 70 |
| Volume | 421,409 |
| Avg. Volume (20D) | 687,762 |
| Open | 67.70 |
| Previous Close | 67.84 |
| Day's Range | 66.43 - 68.01 |
| 52-Week Range | 55.30 - 94.99 |
| Beta | 0.32 |
Analyst Forecast
According to 0 analyst ratings, the average rating for HAE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+5.85%
Haemonetics shares are trading higher after the co...
Unlock content with
Pro Subscription
3 months ago
-11.58%
Haemonetics shares are trading lower after the company reported Q3 financial results and missed its revenue estimate.
